BlaidsX Neuro vs Starkey Evolv AI

The BlaidsX Neuro is a mid-priced behind-the-ear OTC hearing aid priced at $799, earning a B grade with a SoundScore of 3.4/5 in our lab testing. This places it in the top 68% of OTC hearing aids tested, though it falls below the category average of 3.71. In our testing, the BlaidsX Neuro showed notable strengths in speech clarity for quiet environments, scoring 0.54 points above the category average. Feedback handling was excellent at 5.0/5, ranking among the best we've measured and 0.46 points above average. These results suggest the device may work well for conversations in calm settings where background noise isn't a factor. However, the device showed significant limitations in other areas. Speech in noise performance scored low at 1.0/5, falling 0.48 points below the category average—a concern for users who need help in challenging listening environments. Own-voice comfort also scored below average at 1.7/5, and music streaming scored 0.0/5, making it unsuitable for those who want to stream audio content. At this price point, buyers face strong competition. Devices like the Sony CRE-E10 and Lexie B2 Plus offer substantially higher overall scores in the same price range. The BlaidsX Neuro may suit users who primarily need help with face-to-face conversation in quiet spaces and don't require streaming capabilities, but those seeking versatile performance should consider alternatives.

The Starkey Evolv AI is a premium behind-the-ear prescription hearing aid released in 2022, currently available at $4,598. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #28 of 36 prescription hearing aids tested. This device shows notable strengths in specific performance areas. Music streaming quality stands out at 3.7/5, scoring 1.06 points above the category average—making it a solid choice for users who prioritize audio entertainment. Speech in noise performance reaches 2.8/5, which is 0.81 points above the category average, though the absolute score reflects mixed real-world performance in challenging listening environments. Speech in quiet is solid at 3.4/5, slightly above average. The Evolv AI does show weaknesses in two key areas. Own voice comfort scores 2.1/5, falling 0.65 points below the category average, which may affect how natural your own speech sounds. Feedback handling, while solid in absolute terms at 3.5/5, runs 1.21 points below the category average of 4.71/5—meaning competitors in this price tier generally offer better feedback suppression. At this premium price point, several alternatives deliver stronger overall performance, including the Phonak Sphere Infinio and Oticon Intent. However, the Evolv AI's Expert's Choice Award recognition in 2023 and 2024 reflects its practical strengths. This hearing aid may suit users who prioritize music streaming quality and improved speech understanding in noise over own-voice comfort, and who value Starkey's feature set including rechargeable batteries and hands-free calling for both iPhone and Android.